SEARCH

SEARCH BY CITATION

References

  • 1
    Joffe I, Epstein S: Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum 20: 256272, 1991
  • 2
    Laan RFJM, van Riel PLCM, van de Putte LBA: Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis 51: 826832, 1992
  • 3
    Eggelmeijer F, Camps JAJ, Valkema R, Papapoulos SE, Pauwels EKJ, Dijkmans BAC, Breedveld FC: Bone mineral density in ambulant non-steroid treated female patients with rheumatoid arthritis. Clin Exp Rheumatol 11: 381385, 1993
  • 4
    Hooyman JR, Melton LJ III, Nelson AM, O'Fallon WM, Riggs BL: Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 27: 13531361, 1984
  • 5
    Beat AM, Bloch DA, Fries JF: Predictors of fractures in early rheumatoid arthritis. J Rheumatol 18: 804808, 1991
  • 6
    Spector TD, Hall GM, McCloskey EV, Kanis JA: Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 306: 558561, 1993
  • 7
    Gough AKS, Liley J, Eyre S, Holder RL, Emery P: Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344: 2327, 1994
  • 8
    Sambrook PN: Osteoporosis in rheumatoid arthritis: what is the role of antirheumatic therapy? Lancet 344: 34, 1994
  • 9
    Fleisch H: Bisphosphonates: pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease. Drugs 42: 919944, 1991
  • 10
    Bijvoet OLM, Vellenga CJLR, Harinck HIJ: Paget's disease of bone: assessment, therapy and secondary prevention. In, Clinical Disorders of Bone Mineral Metabolism. Edited by MKleerkoper, SMKrane. New York, Mary Ann Liebert Inc., 1989
  • 11
    Valkema R, Vismans FJFE, Papapoulos SE, Pauwels EKJ, Bijvoet OLM: Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner 5: 183192, 1989
  • 12
    Adami S, Baroni MC, Broggini M, Carratelli L, Caruso I, Gnessi L, Laurenzi M, Lombardi A, Norbiato G, Ortolani S: Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin. Osteoporosis Int 3 (Suppl 3): 2127, 1993
  • 13
    Reid IR, Wattie DJ, Evans MC, Gamble JD, Stapleton JF, Cornisk J: Continuous therapy with panidronate, a potent bisphosphatae, in postmenopausal osteoporosis. J Clin Endocrinol Metab 79: 15951599, 1994
  • 14
    Papapoulos SE, Landman JD, Bijvoet OLM, Löwik CWGM, Valkema R, Pauwels EKJ, Vermeij P: The use of bisphosphonate in the treatment of osteoporosis. Bone 13: 541549, 1992
  • 15
    Papapoulos SE: The role of bisphosphonates in the prevention and treatment of osteoporosis. Am J Med 95 (Suppl 5A): 4851, 1993
  • 16
    Eggelmeijer F, Papapoulos SE, van Paassen HC, Dijkmans BAC, Breedveld FC: Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double-blind placebo controlled study. J Rheumatol 21: 20162020, 1994
  • 17
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315324, 1988
  • 18
    Steinbrocker O, Traeger CH, Batterman EC: Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659662, 1949
  • 19
    Kellgren JH, Jeffrey MR, Ball J: Atlas of standard radiographs of arthritis. Oxford, Blackwell Scientific Publications, 1963
  • 20
    Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 393406, 1968
  • 21
    Fries JF, Spitz P, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 23: 137145, 1980
  • 22
    Prockop DJ, Undenfriend S: A specific method of the analysis of hydroxyproline in tissues and urine. Anal Biochem 1: 228233, 1960
  • 23
    Shenstone BD, Mahmoud A, Woodwars R, Elvins D, Palmer R, Ring EF, Bhalla AK: Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 33: 541545, 1994
  • 24
    Van den Brink HR, Lems WF, Van Everdingen AA, Bijlsma JWJ: Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann Rheum Dis 52: 302305, 1993
  • 25
    Sambrook PN, Cohen ML, Eisman JA, Pocock NA, Champion GD, Yeates MG: Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: a longitudinal study. Ann Rheum Dis 48: 535538, 1989
  • 26
    Laan RFJM, van Riel PLCM, van de Putte LBA, van Erning LJTO, van 't Hof MA, Lemmens JAM: Low-dose prednisone induced rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 119: 963968, 1993
  • 27
    Gough AKS, Peel NFA, Eastell R, Holder RL, Lilley J, Emery P: Excretion of pyridinoline crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 53: 1417, 1994
  • 28
    Eggelmeijer F, Papapoulos SE, Westedt ML, van Paassen HC, Dijkmans BAC, Breedveld FC: Bone metabolism in rheumatoid arthritis; relation to disease activity. Br J Rheumatol 32: 387391, 1993
  • 29
    Harinck HIJ, Bijvoet OLM, Blanksma HJ, Dahlinghaus-Nienhuys PJ: Efficacious management with amino bisphosphonates (APD) in Paget's disease of bone. Clin Orthop 217: 7998, 1987
  • 30
    Van Holten-Verzantvoort AT, Kroon HM, Bijvoet OLM, Cleton FJ, Beex LVAM, Blijham G, Hermans J, Neijt JP, Papapoulos SE, Sleeboom HP, Vermey P, Zwinderman AH: Palliative pamidronate treatment in patients with bone metastasis for breast cancer. J Clin Oncol 11: 491498, 1993
  • 31
    Flora L: Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis. Arthritis Rheum 22: 340346, 1979
  • 32
    Barbier A, Brelière JC, Remandet B, Roncucci R: Studies on the chronic phase of adjuvant arthritis: effect of SR 41319 a new diphosphonate. Ann Rheum Dis 45: 6774, 1986
  • 33
    Bijvoet OLM, Frijlink WB, Jie K, van der Linden H, Meijer CJLM, Mulder H, van Paassen HC, Reitsma PH, te Velde J, de Vries E, van der Wey JP: APD in Paget's disease of bone: role of the mononuclear phagocyte system? Arthritis Rheum 23: 11931204, 1980
  • 34
    Tan PLJ, Ames R, Yeoman S, Ibbertson HK, Caughey DE: Effects of aminobisphosphonate infusion on biochemical indices of bone metabolism in rheumatoid arthritis. Preliminary report. Br J Rheumatol 28: 325328, 1989
  • 35
    Maccagno A, Di Giorgio E, Roldan EJA, Caballero LE, Perez Lloret A: Double blind radiological assessment of continuous oral pamidronate in patients with rheumatoid arthritis. Scand J Rheumatol 23: 211214, 1994